72
Views
1
CrossRef citations to date
0
Altmetric
Review Articles

Microbial metabolite effects on TLR to develop autoimmune diseases

, , , &
Pages 273-289 | Received 13 Aug 2017, Accepted 23 Apr 2018, Published online: 22 May 2018

References

  • Abate, G., et al., 2004. Direct colorimetric assay for rapid detection of rifampin-resistant Mycobacterium tuberculosis. Journal of clinical microbiology, 42 (2), 871–873.
  • Abriouel, H., et al., 2008. Comparative analysis of genetic diversity and incidence of virulence factors and antibiotic resistance among enterococcal populations from raw fruit and vegetable foods, water and soil, and clinical samples. International journal of food microbiology, 123 (1–2), 38–49.
  • Agarwal, R.K., et al., 2002. Pertussis toxin alters the innate and the adaptive immune responses in a pertussis-dependent model of autoimmunity. Journal of neuroimmunology, 129 (1), 133–140.
  • Akashi, S., et al., 2000. Regulatory roles for CD14 and phosphatidylinositol in the signaling via toll-like receptor 4-MD-2. Biochemical and biophysical research communications, 268 (1), 172–177.
  • Albiger, B., et al., 2007. Role of the innate immune system in host defence against bacterial infections: focus on the Toll-like receptors. Journal of internal medicine, 261 (6), 511–528.
  • Avila-Calderón, E.D., et al., 2015. Roles of bacterial membrane vesicles. Archives of microbiology, 197 (1), 1–10.
  • Baker, B., et al., 2003. Normal keratinocytes express toll‐like receptors (TLRs) 1, 2 and 5: modulation of TLR expression in chronic plaque psoriasis. British journal of dermatology, 148 (4), 670–679.
  • Bambou, J.C., et al., 2004. In vitro and ex vivo activation of the TLR5 signaling pathway in intestinal epithelial cells by a commensal Escherichia coli strain. Journal of biological chemistry, 279 (41), 42984–42992.
  • Banchereau, J. and Steinman, R.M., 1998. Dendritic cells and the control of immunity. Nature, 392 (6673), 245–252.
  • Barak, B., Feldman, N., and Okun, E., 2014. Toll-like receptors as developmental tools that regulate neurogenesis during development: an update. Frontiers in neuroscience, 8, 272.
  • Belkaid, Y. and Hand, T.W., 2014. Role of the microbiota in immunity and inflammation. Cell, 157 (1), 121–141.
  • Berry, A., et al., 1989. Reduced virulence of a defined pneumolysin-negative mutant of Streptococcus pneumoniae. Infection and immunity, 57 (7), 2037–2042.
  • Beutler, B. and Rietschel, E.T., 2003. Innate immune sensing and its roots: the story of endotoxin. Nature reviews immunology, 3 (2), 169–176.
  • Blasius, A.L. and Beutler, B., 2010. Intracellular toll-like receptors. Immunity, 32 (3), 305–315.
  • Brabb, T., et al., 1997. Triggers of autoimmune disease in a murine TCR-transgenic model for multiple sclerosis. The journal of immunology, 159 (1), 497–507.
  • Bueno, S., et al., 2010. Virulence mechanisms displayed by Salmonella to impair dendritic cell function. Current medicinal chemistry, 17 (12), 1156–1166.
  • Burcelin, R., Courtney, M., and Amar, J., 2015. Gut microbiota and metabolic diseases: from pathogenesis to therapeutic perspective. In: Metabonomics and gut microbiota in nutrition and disease. London: Springer, 199–234.
  • Buzas, E.I., et al., 2014. Emerging role of extracellular vesicles in inflammatory diseases. Nature reviews rheumatology, 10 (6), 356–364.
  • Cadwell, K., 2014. Expanding the role of the virome: commensalism in the gut. Journal of virology, JVI, 02966–02914.
  • Cario, E. and Podolsky, D.K., 2000. Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infection and immunity, 68 (12), 7010–7017.
  • Cario, E., et al., 2000. Lipopolysaccharide activates distinct signaling pathways in intestinal epithelial cell lines expressing Toll-like receptors. Journal of immunology (Baltimore, MD: 1950), 164 (2), 966–972.
  • Cario, E., Gerken, G., and Podolsky, D.K., 2004. Toll-like receptor 2 enhances ZO-1-associated intestinal epithelial barrier integrity via protein kinase C. Gastroenterology, 127 (1), 224–238.
  • Cerf-Bensussan, N. and Gaboriau-Routhiau, V., 2010. The immune system and the gut microbiota: friends or foes? Nature reviews. Immunology, 10 (10), 735–744.
  • Chervonsky, A., 2009. Innate receptors and microbes in induction of autoimmunity. Current opinion in immunology, 21 (6), 641–647.
  • Christensen, S.R. and Shlomchik, M.J., eds., 2007. Regulation of lupus-related autoantibody production and clinical disease by Toll-like receptors. Seminars in immunology, 19 (1), 11–23.
  • de Goffau, M.C., et al., 2014. Aberrant gut microbiota composition at the onset of type 1 diabetes in young children. Diabetologia, 57 (8), 1569–1577.
  • de Kivit, S., et al., 2014. Regulation of intestinal immune responses through TLR activation: implications for pro- and prebiotics. Frontiers in immunology, 5, 60.
  • Deatherage, B.L. and Cookson, B.T., 2012. Membrane vesicle release in bacteria, eukaryotes, and archaea: a conserved yet underappreciated aspect of microbial life. Infection and immunity, 80 (6), 1948–1957.
  • Deng, G.-M. and Tsokos, G.C., 2008. Cholera toxin B accelerates disease progression in lupus-prone mice by promoting lipid raft aggregation. Journal of immunology (Baltimore, MD: 1950), 181 (6), 4019–4026.
  • Desreumaux, P., et al., 2001. Attenuation of colon inflammation through activators of the retinoid X receptor (RXR)/peroxisome proliferator-activated receptor gamma (PPARgamma) heterodimer. A basis for new therapeutic strategies. The journal of experimental medicine, 193 (7), 827–838.
  • Diebold, S.S., 2008. Determination of T-cell fate by dendritic cells. Immunology and cell biology, 86 (5), 389–397.
  • Dogi, C.A., Galdeano, C.M., and Perdigón, G., 2008. Gut immune stimulation by non pathogenic Gram(+) and Gram(–) bacteria. Comparison with a probiotic strain. Cytokine, 41 (3), 223–231.
  • Dolganiuc, A., et al., 2006. Acute ethanol treatment modulates Toll‐like receptor‐4 association with lipid rafts. Alcoholism: clinical and experimental research, 30 (1), 76–85.
  • Du, C., et al., 2002. Chlamydia pneumoniae infection of the central nervous system worsens experimental allergic encephalitis. The journal of experimental medicine, 196 (12), 1639–1644.
  • Ebringer, A., Rashid, T., and Wilson, C., 2010. Rheumatoid arthritis, Proteus, anti-CCP antibodies and Karl Popper. Autoimmunity reviews, 9 (4), 216–223.
  • Edelson, B.T. and Unanue, E.R., 2002. MyD88-dependent but Toll-like receptor 2-independent innate immunity to Listeria: no role for either in macrophage listericidal activity. Journal of immunology (Baltimore, MD: 1950), 169 (7), 3869–3875.
  • Falk, P.G., et al., 1998. Creating and maintaining the gastrointestinal ecosystem: what we know and need to know from gnotobiology. Microbiology and molecular biology reviews, 62 (4), 1157–1170.
  • Faure, E., et al., 2000. Bacterial lipopolysaccharide activates NF-kappaB through toll-like receptor 4 (TLR-4) in cultured human dermal endothelial cells. Differential expression of TLR-4 and TLR-2 in endothelial cells. The journal of biological chemistry, 275 (15), 11058–11063.
  • Fischer, H., et al., 2006. Mechanism of pathogen-specific TLR4 activation in the mucosa: fimbriae, recognition receptors and adaptor protein selection. European journal of immunology, 36 (2), 267–277.
  • Fischer, M. and Ehlers, M., 2008. Toll-like receptors in autoimmunity. Annals of the New York academy of sciences, 1143, 21–34.
  • França, T.G.D., et al., 2014. Previous infection with Staphylococcus aureus strains attenuated experimental encephalomyelitis. BMC neuroscience, 15 (1), 8.
  • Froy, O. and Chapnik, N., 2007. Circadian oscillation of innate immunity components in mouse small intestine. Molecular immunology, 44 (8), 1954–1960.
  • Fujimoto, C., et al., 2006. Pertussis toxin is superior to TLR ligands in enhancing pathogenic autoimmunity, targeted at a neo-self antigen, by triggering robust expansion of Th1 cells and their cytokine production. The journal of immunology, 177 (10), 6896–6903.
  • Furrie, E., et al., 2005. Toll-like receptors-2, -3 and -4 expression patterns on human colon and their regulation by mucosal-associated bacteria. Immunology, 115 (4), 565–574.
  • Geissmann, F., et al., 2010. Development of monocytes, macrophages, and dendritic cells. Science (New York, N.Y.), 327 (5966), 656–661.
  • Gekara, N.O., et al., 2009. Signals triggered by a bacterial pore-forming toxin contribute to toll-like receptor redundancy in gram-positive bacterial recognition. The journal of infectious diseases, 199 (1), 124–133.
  • Gewirtz, A.T., et al., 2001a. Cutting edge: bacterial flagellin activates basolaterally expressed TLR5 to induce epithelial proinflammatory gene expression. Journal of immunology (Baltimore, MD: 1950), 167 (4), 1882–1885.
  • Gewirtz, A.T., et al., 2001b. Salmonella typhimurium translocates flagellin across intestinal epithelia, inducing a proinflammatory response. Journal of clinical investigation, 107 (1), 99–109.
  • Ghadimi, D., et al., 2010. Effect of natural commensal-origin DNA on toll-like receptor 9 (TLR9) signaling cascade, chemokine IL-8 expression, and barrier integrity of polarized intestinal epithelial cells. Inflammatory bowel diseases, 16 (3), 410–427.
  • Gilden, D.H., 1999. Chlamydia: a role for multiple sclerosis or more confusion? Annals of neurology, 46 (1), 4–5.
  • Gomariz, R.P., et al., 2005. Time-course expression of Toll-like receptors 2 and 4 in inflammatory bowel disease and homeostatic effect of VIP. Journal of leukocyte biology, 78 (2), 491–502.
  • Gómez-Llorente, C., Munoz, S., and Gil, A., 2010. Role of Toll-like receptors in the development of immunotolerance mediated by probiotics. Proceedings of the nutrition society, 69 (03), 381–389.
  • Gratz, I.K., et al., 2014. Cutting edge: self-antigen controls the balance between effector and regulatory T cells in peripheral tissues. The journal of immunology, 192 (4), 1351–1355.
  • Gupta, R.A., et al., 2001. Activation of peroxisome proliferator-activated receptor gamma suppresses nuclear factor kappa B-mediated apoptosis induced by Helicobacter pylori in gastric epithelial cells. The journal of biological chemistry, 276 (33), 31059–31066.
  • Hampe, J., et al., 1999. A genomewide analysis provides evidence for novel linkages in inflammatory bowel disease in a large European cohort. The American journal of human genetics, 64 (3), 808–816.
  • Hara, N., et al., 2013. The role of the intestinal microbiota in type 1 diabetes. Clinical immunology (Orlando, FL), 146 (2), 112–119.
  • Hara, Y., et al., 1996. Serum rheumatoid factor induced by intraperitoneal administration of periodontopathic bacterial lipopolysaccharide in mice. Journal of periodontal research, 31 (7), 502–507.
  • Harris, G., KuoLee, R., and Chen, W., 2006. Role of Toll-like receptors in health and diseases of gastrointestinal tract. World journal of gastroenterology, 12 (14), 2149.
  • Harris, G., KuoLee, R., and Chen, W., 2006. Role of Toll-like receptors in health and diseases of gastrointestinal tract. World journal of gastroenterology, 12 (14), 2149–2160.
  • Herrmann, I., et al., 2006. Streptococcus pneumoniae infection aggravates experimental autoimmune encephalomyelitis via Toll-like receptor 2. Infection and immunity, 74 (8), 4841–4848.
  • Hong, S.W., et al., 2011. Extracellular vesicles derived from Staphylococcus aureus induce atopic dermatitis-like skin inflammation. Allergy, 66 (3), 351–359.
  • Hooper, L.V. and Gordon, J.I., 2001. Commensal host-bacterial relationships in the gut. Science (New York, N.Y.), 292 (5519), 1115–1118.
  • Hosseini, A.M., et al., 2015. Toll-like receptors in the pathogenesis of autoimmune diseases. Advanced pharmaceutical bulletin, 3, 10–16.
  • Hou, W., et al., 2003. Pertussis toxin enhances Th1 responses by stimulation of dendritic cells. Journal of immunology (Baltimore, MD: 1950), 170 (4), 1728–1736.
  • Iemoli, E., et al., 2012. Probiotics reduce gut microbial translocation and improve adult atopic dermatitis. Journal of clinical gastroenterology, 46 (Suppl.), S33–S40.
  • Imani Fooladi, A.A., et al., 2012. Probiotic as a novel treatment strategy against liver disease. Hepatitis monthly, 12 (11), e7521.
  • Ioannou, S. and Voulgarelis, M., 2010. Toll-like receptors, tissue injury, and tumourigenesis. Mediators of inflammation, 2010, pii: 581837.
  • Iruretagoyena, M.I., Wiesendanger, M., and Kalergis, A.M., 2006. The dendritic cell-T cell synapse as a determinant of autoimmune pathogenesis. Current pharmaceutical design, 12 (2), 131–147.
  • Jung, H.C., et al., 1995. A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion. Journal of clinical investigation, 95 (1), 55.
  • Kaneko, Y., Nimmerjahn, F., and Ravetch, J.V., 2006. Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation. Science (New York, NY), 313 (5787), 670–673.
  • Kaparakis, M., et al., 2010. Bacterial membrane vesicles deliver peptidoglycan to NOD1 in epithelial cells. Cellular microbiology, 12 (3), 372–385.
  • Kawasaki, T. and Kawai, T., 2014. Toll-like receptor signaling pathways. Frontiers in immunology, 5, 461.
  • Kayserova, J., et al., 2014. Decreased dendritic cell numbers but increased TLR9-mediated interferon-alpha production in first degree relatives of type 1 diabetes patients. Clinical immunology, 153 (1), 49–55.
  • Khani, S., et al., 2012. Probiotics as an alternative strategy for prevention and treatment of human diseases: a review. Inflammation & allergy-drug targets, 11 (2), 79–89.
  • Kielian, T., et al., 2005. Toll-like receptor 2 modulates the proinflammatory milieu in Staphylococcus aureus-induced brain abscess. Infection and immunity, 73 (11), 7428–7435.
  • Kim, Y.H., et al., 1999. Apoptosis of pancreatic beta-cells detected in accelerated diabetes of NOD mice: no role of Fas-Fas ligand interaction in autoimmune diabetes. European journal of immunology, 29 (2), 455–465.
  • Knapp, S., et al., 2004. Toll-like receptor 2 plays a role in the early inflammatory response to murine pneumococcal pneumonia but does not contribute to antibacterial defense. The journal of immunology, 172 (5), 3132–3138.
  • Koedel, U., et al., 2003. Toll-like receptor 2 participates in mediation of immune response in experimental pneumococcal meningitis. Journal of immunology (Baltimore, MD: 1950), 170 (1), 438–444.
  • Komatsuda, A., et al., 2008. Up-regulated expression of Toll-like receptors mRNAs in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Clinical and experimental immunology, 152 (3), 482–487.
  • Kopp, E. and Medzhitov, R., 2003. Recognition of microbial infection by Toll-like receptors. Current opinion in immunology, 15 (4), 396–401.
  • Lampropoulou, V., et al., 2008. TLR-activated B cells suppress T cell-mediated autoimmunity. The journal of immunology, 180 (7), 4763–4773.
  • Lebre, M.C., et al., 2007. Human keratinocytes express functional Toll-like receptor 3, 4, 5, and 9. The journal of investigative dermatology, 127 (2), 331–341.
  • Li, X., et al., 2013. Toll-like receptor 4 increases intestinal permeability through up-regulation of membrane PKC activity in alcoholic steatohepatitis. Alcohol, 47 (6), 459–465.
  • Libbey, J.E., Cusick, M.F., and Fujinami, R.S., 2014. Role of pathogens in multiple sclerosis. International reviews of immunology, 33 (4), 266–283.
  • Libby, P., Ridker, P.M., and Maseri, A., 2002. Inflammation and atherosclerosis. Circulation, 105 (9), 1135–1143.
  • Lin, X.P., Almqvist, N., and Telemo, E., 2005. Human small intestinal epithelial cells constitutively express the key elements for antigen processing and the production of exosomes. Blood cells, molecules & diseases, 35 (2), 122–128.
  • Linthicum, D.S., Munoz, J.J., and Blaskett, A., 1982. Acute experimental autoimmune encephalomyelitis in mice: I. Adjuvant action of Bordetella pertussis is due to vasoactive amine sensitization and increased vascular permeability of the central nervous system. Cellular immunology, 73 (2), 299–310.
  • Liu, Z.-Q., et al., 2001. Staphylococcal peptidoglycans induce arthritis. Arthritis research, 3 (6), 375–380.
  • Llanos, C., et al., 2011. Genetic and pharmacological modulation of dendritic cell-T cell interactions as a therapeutic strategy for systemic lupus erythematosus. Current gene therapy, 11 (6), 544–553.
  • Mackern-Oberti, J.P., et al., 2015. Role of dendritic cells in the initiation, progress and modulation of systemic autoimmune diseases. Autoimmunity reviews, 14 (2), 127–139.
  • MacPherson, G., et al., 1995. Endotoxin-mediated dendritic cell release from the intestine. Characterization of released dendritic cells and TNF dependence. Journal of immunology (Baltimore, MD: 1950), 154 (3), 1317–1322.
  • Marta, M., et al., 2008. Unexpected regulatory roles of TLR4 and TLR9 in experimental autoimmune encephalomyelitis. European journal of immunology, 38 (2), 565–575.
  • Mayer, L., et al., 1991. Expression of class II molecules on intestinal epithelial cells in humans. Differences between normal and inflammatory bowel disease. Gastroenterology, 100 (1), 3–12.
  • Mazmanian, S.K., et al., 2005. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell, 122 (1), 107–118.
  • Means, T.K., et al., 1999. The CD14 ligands lipoarabinomannan and lipopolysaccharide differ in their requirement for Toll-like receptors. The journal of immunology (Baltimore, MD: 1950), 163 (12), 6748–6755.
  • Miettinen, M., et al., 2008. Live Lactobacillus rhamnosus and Streptococcus pyogenes differentially regulate Toll-like receptor (TLR) gene expression in human primary macrophages. Journal of leukocyte biology, 84 (4), 1092–1100.
  • Miller, L.S., et al., 2006. MyD88 mediates neutrophil recruitment initiated by IL-1R but not TLR2 activation in immunity against Staphylococcus aureus. Immunity, 24 (1), 79–91.
  • Miranda-Hernandez, S., et al., 2011. Role for MyD88, TLR2 and TLR9 but not TLR1, TLR4 or TLR6 in experimental autoimmune encephalomyelitis. Journal of immunology (Baltimore, MD: 1950), 187 (2), 791–804.
  • Mullaly, S.C. and Kubes, P., 2006. The role of TLR2 in vivo following challenge with Staphylococcus aureus and prototypic ligands. The journal of immunology (Baltimore, MD: 1950), 177 (11), 8154–8163.
  • Nakahira, K., et al., 2006. Carbon monoxide differentially inhibits TLR signaling pathways by regulating ROS-induced trafficking of TLRs to lipid rafts. The journal of experimental medicine, 203 (10), 2377–2389.
  • Netea, M.G., Wijmenga, C., and O'Neill, L.A., 2012. Genetic variation in Toll-like receptors and disease susceptibility. Nature immunology, 13 (6), 535–542.
  • Nichols, F.C., et al., 2009. Unique lipids from a common human bacterium represent a new class of Toll-like receptor 2 ligands capable of enhancing autoimmunity. The American journal of pathology, 175 (6), 2430–2438.
  • Nomura, F., et al., 2000. Cutting edge: endotoxin tolerance in mouse peritoneal macrophages correlates with down-regulation of surface toll-like receptor 4 expression. Journal of immunology (Baltimore, MD: 1950), 164 (7), 3476–3479.
  • O’Brien, B.A., et al., 1997. Apoptosis is the mode of β-cell death responsible for the development of IDDM in the nonobese diabetic (NOD) mouse. Diabetes, 46 (5), 750–757.
  • Ochoa‐Repáraz, J., et al., 2011. Gut, bugs, and brain: role of commensal bacteria in the control of central nervous system disease. Annals of neurology, 69 (2), 240–247.
  • Ohtani, K. and Shimizu, T., 2014. Regulation of toxin gene expression in Clostridium perfringens. Research in microbiology, 166 (4), 280–289.
  • O’Neill, L.A., 2002. Toll-like receptor signal transduction and the tailoring of innate immunity: a role for Mal? Trends in immunology, 23 (6), 296–300.
  • Opipari, A. and Franchi, L., 2015. Role of inflammasomes in intestinal inflammation and Crohn's disease. Inflammatory bowel diseases, 21 (1), 173–181.
  • Ospelt, C. and Gay, S., 2010. TLRs and chronic inflammation. International journal of biochemistry & cell biology, 42 (4), 495–505.
  • Otte, J.M., Rosenberg, I.M., and Podolsky, D.K., 2003. Intestinal myofibroblasts in innate immune responses of the intestine. Gastroenterology, 124 (7), 1866–1878.
  • Park, J.M., et al., 2004. Anthrolysin O and other gram-positive cytolysins are toll-like receptor 4 agonists. The journal of experimental medicine, 200 (12), 1647–1655.
  • Pearce, E.J. and Everts, B., 2015. Dendritic cell metabolism. Nature reviews. Immunology, 15 (1), 18–29.
  • Perez, V.L., et al., 1997. Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement. Immunity, 6 (4), 411–417.
  • Pierer, M., et al., 2004. Chemokine secretion of rheumatoid arthritis synovial fibroblasts stimulated by Toll-like receptor 2 ligands. Journal of immunology (Baltimore, MD: 1950), 172 (2), 1256–1265.
  • Pletinckx, K., et al., 2014. Immature dendritic cells convert anergic nonregulatory T cells into Foxp3−IL-10+ regulatory T cells by engaging CD28 and CTLA‐4. European journal of immunology, 45 (2), 480–491.
  • Podolsky, D.K., 1991. Inflammatory bowel disease (1). The New England journal of medicine, 325 (13), 928–937.
  • Portnoy, D.A., et al., 1992. Molecular determinants of Listeria monocytogenes pathogenesis. Infection and immunity, 60 (4), 1263.
  • Qin, J., et al., 2010. A human gut microbial gene catalogue established by metagenomic sequencing. Nature, 464 (7285), 59–65.
  • Qureshi, S.T., et al., 1999. Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4). The journal of experimental medicine, 189 (4), 615–625.
  • Rakoff-Nahoum, S., Hao, L., and Medzhitov, R., 2006. Role of toll-like receptors in spontaneous commensal-dependent colitis. Immunity, 25 (2), 319–329.
  • Ramos, H.C., Rumbo, M., and Sirard, J.C., 2004. Bacterial flagellins: mediators of pathogenicity and host immune responses in mucosa. Trends in microbiology, 12 (11), 509–517.
  • Rogler, G., et al., 1997. Alterations of the phenotype of colonic macrophages in inflammatory bowel disease. European journal of gastroenterology & hepatology, 9 (9), 893–899.
  • Round, J.L. and Mazmanian, S.K., 2009. The gut microbiota shapes intestinal immune responses during health and disease. Nature reviews immunology, 9 (5), 313–323.
  • Ryu, K.A., et al., 2014. Stimulation of innate immune cells by light-activated TLR7/8 agonists. Journal of the American chemical society, 136 (31), 10823–10825.
  • Sarvtin, M.T., et al., 2013. An overview on the role of microbial agents in psoriasis. Journal of Mazandaran university of medical sciences (JMUMS), 23 (98), 364–385.
  • Schiffenbauer, J., et al., 1993. Staphylococcal enterotoxins can reactivate experimental allergic encephalomyelitis. Proceedings of the national academy of sciences, 90 (18), 8543–8546.
  • Schraml, B.U. and e Sousa, C.R., 2015. Defining dendritic cells. Current opinion in immunology, 32, 13–20.
  • Sebastiani, G., et al., 2000. Cloning and characterization of the murine toll-like receptor 5 (Tlr5) gene: sequence and mRNA expression studies in Salmonella-susceptible MOLF/Ei mice. Genomics, 64 (3), 230–240.
  • Seibl, R., et al., 2003. Expression and regulation of Toll-like receptor 2 in rheumatoid arthritis synovium. The American journal of pathology, 162 (4), 1221–1227.
  • Silver, A.C., et al., 2012. The circadian clock controls toll-like receptor 9-mediated innate and adaptive immunity. Immunity, 36 (2), 251–261.
  • Sodhi, C., et al., 2011. DNA attenuates enterocyte Toll-like receptor 4-mediated intestinal mucosal injury after remote trauma. American journal of physiology. Gastrointestinal and liver physiology, 300 (5), G862–G873.
  • Sonnenburg, J.L., Angenent, L.T., and Gordon, J.I., 2004. Getting a grip on things: how do communities of bacterial symbionts become established in our intestine? Nature immunology, 5 (6), 569–573.
  • Steinbach, E.C. and Plevy, S.E., 2014. The role of macrophages and dendritic cells in the initiation of inflammation in IBD. Inflammatory bowel diseases, 20 (1), 166–175.
  • Strobel, S. and Mowat, A.M., 2006. Oral tolerance and allergic responses to food proteins. Current opinion in allergy and clinical immunology, 6 (3), 207–213.
  • Strober, W., Fuss, I.J., and Blumberg, R.S., 2002. The immunology of mucosal models of inflammation 1. Annual review of immunology, 20 (1), 495–549.
  • Tartey, S. and Takeuchi, O., 2014. Toll‐like receptors: role in inflammation and cancer. Cancer and inflammation mechanisms: chemical, biological, and clinical aspects, Chap. 7, Wiley online library, 83–102.
  • Tauber, S.C., Nau, R., and Gerber, J., 2007. Systemic infections in multiple sclerosis and experimental autoimmune encephalomyelitis. Archives of physiology and biochemistry, 113 (3), 124–130.
  • Terlizzi, M., Pinto, A., and Sorrentino, R., 2015. Role of plasmacytoid dendritic cells in cancer. Cancer Immunology: Springer, 1771–1794.
  • Tohno, M., et al., 2005. Toll-like receptor 2 is expressed on the intestinal M cells in swine. Biochemical and biophysical research communications, 330 (2), 547–554.
  • Torre, D., et al., 1993. Production and release of tumornecrosis factor alfa, interleukin-1B and interleukin-6 by human mononuclear leukocytes stimulated with pertussis toxin. The new microbiologica, 16 (4), 309–314.
  • Torres, B.A., et al., 2001. Superantigens: the good, the bad, and the ugly. Experimental biology and medicine (Maywood, NJ), 226 (3), 164–176.
  • Torres, D., et al., 2004. Toll-like receptor 2 is required for optimal control of Listeria monocytogenes infection. Infection and immunity, 72 (4), 2131–2139.
  • Travassos, L.H., et al., 2004. Toll-like receptor 2-dependent bacterial sensing does not occur via peptidoglycan recognition. EMBO reports, 5 (10), 1000–1006.
  • Triantafilou, M. and Triantafilou, K., 2002. Lipopolysaccharide recognition: CD14, TLRs and the LPS-activation cluster. Trends in immunology, 23 (6), 301–304.
  • Vijay-Kumar, M., et al., 2010. Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science (New York, N.Y.), 328 (5975), 228–231.
  • Wang, R., et al., 2006. HSP70 enhances macrophage phagocytosis by interaction with lipid raft-associated TLR-7 and upregulating p38 MAPK and PI3K pathways. The journal of surgical research, 136 (1), 58–69.
  • Wilson, M.S., et al., 2010. Helminth‐induced CD19+ CD23hi B cells modulate experimental allergic and autoimmune inflammation. European journal of immunology, 40 (6), 1682–1696.
  • Yu, P., et al., 2006. Toll-like receptor 9-independent aggravation of glomerulonephritis in a novel model of SLE. International immunology, 18 (8), 1211–1219.
  • Zare, F., et al., 2004. Arthritogenic properties of double-stranded (viral) RNA. Journal of immunology (Baltimore, MD: 1950), 172 (9), 5656–5663.
  • Zhang, G. and Ghosh, S., 2002. Negative regulation of toll-like receptor-mediated signaling by Tollip. The journal of biological chemistry, 277 (9), 7059–7065.
  • Zipris, D., 2009. Epidemiology of type 1 diabetes and what animal models teach us about the role of viruses in disease mechanisms. Clinical immunology (Orlando, FL), 131 (1), 11–23.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.